Arthritis News and Research

Latest Arthritis News and Research

Workers in certain jobs face increased risk of developing knee osteoarthritis

Workers in jobs that typically involve heavy lifting, frequent climbing, prolonged kneeling, squatting, and standing face an increased risk of developing knee osteoarthritis.

8 Jul 2020

QUT and Oxford collaborate on clinical trial to test asthma inhalers as treatment for COVID-19

QUT researchers are collaborating with colleagues at the University of Oxford on a UK clinical trial to test common asthma inhalers as a treatment for COVID-19 infection.

8 Jul 2020

Methotrexate is not an additional risk factor for interstitial lung disease in RA patients

Patients with rheumatoid arthritis (RA) often suffer from what is referred to as interstitial lung disease (ILD).

7 Jul 2020

National Psoriasis Foundation announces $3.28 million in research grants and fellowships

The National Psoriasis Foundation, NPF, is proud to announce the awarding of $3.28 million in research grants and fellowships in 2020.

6 Jul 2020

2021 health plans granted leeway to limit consumers’ benefit from drug coupons

Without medication to manage her plaque psoriasis, Jennifer Brown's face, scalp, trunk and neck periodically become covered in painful red, flaky patches so dry they crack and bleed.

6 Jul 2020

Latest findings put Benson Viscometers at the forefront of Covid-19 fight

A clinical viscosity diagnostic instrument is proving to be valuable in the research and treatment of coronavirus after laboratory scientists have identified its ability to provide meaningful data for medical teams treating Covid-19 patients.

3 Jul 2020

New drug discovery shows promise in fighting acute respiratory illnesses

A collaboration between the University of Toronto's Faculty of Dentistry and the National Jewish Health in Denver -- the top-ranked respiratory research hospital in the U.S. -- has yielded a new drug discovery that could be useful to combat inflammation of all varieties and shows promise in fighting acute respiratory illnesses such as COVID-19.

2 Jul 2020

Repurposed drug for acute lung injury in COVID-19

Now, a new study addresses the possible use of an FDA-approved monoclonal antibody, called fostamatinib, a spleen tyrosine kinase inhibitor (SYK), to reduce the levels of mucin-1, a molecule associated with acute lung injury and acute respiratory distress syndrome (ARDS). People who have severe COVID-19 disease may develop ARDS.

2 Jul 2020

Study reveals the role of glucocorticoid metabolism and GILZ regulation during aging

Why do we age? What exactly is happening in our bodies? And can we do anything about it? Mankind has sought answers to these questions since time immemorial.

1 Jul 2020

ACR releases position statement supporting the role of telemedicine in rheumatology

The American College of Rheumatology (ACR) has released an official position statement supporting the role of telemedicine as a tool with the potential to increase access and improve care for patients with rheumatic diseases.

29 Jun 2020

Study identifies new allergy pathway

Researchers at Johns Hopkins Bloomberg School of Public Health have identified the sequence of molecular events by which tiny, tick-like creatures called house dust mites trigger asthma and allergic rhinitis.

25 Jun 2020

Protein profile in serum reflects COVID-19 severity

The wide range of manifestations of COVID-19 has continued to baffle investigators. Now, a new study published on the preprint server medRxiv in June 2020 shows that blood proteins in COVID-19 patients change over time, and these can possibly predict or reflect the severity of disease. More, they may present targets for treatment.

25 Jun 2020

Increase in sedentary behavior can contribute to cardiovascular health deterioration

The adverse side effects of the social isolation measures implemented to combat COVID-19 include an increase in sedentary behavior and physical inactivity, which can contribute to a deterioration in cardiovascular health even in the short term. Older people and people with chronic diseases tend to be most affected.

24 Jun 2020

Arthritis News and Research

Latest Arthritis News and Research

Workers in certain jobs face increased risk of developing knee osteoarthritis

QUT and Oxford collaborate on clinical trial to test asthma inhalers as treatment for COVID-19

Methotrexate is not an additional risk factor for interstitial lung disease in RA patients

National Psoriasis Foundation announces $3.28 million in research grants and fellowships

2021 health plans granted leeway to limit consumers’ benefit from drug coupons

Latest findings put Benson Viscometers at the forefront of Covid-19 fight

New drug discovery shows promise in fighting acute respiratory illnesses

Repurposed drug for acute lung injury in COVID-19

Study reveals the role of glucocorticoid metabolism and GILZ regulation during aging

ACR releases position statement supporting the role of telemedicine in rheumatology

Study identifies new allergy pathway

Protein profile in serum reflects COVID-19 severity

Increase in sedentary behavior can contribute to cardiovascular health deterioration

Research shows females use anti-inflammatory T cells to maintain their blood pressure

UTHealth tests arthritis drug's effect on COVID-19-induced cytokine storm

Repurposing immunosuppressants to manage COVID-19

Early intensive treatment of rheumatoid arthritis offers an opportunity to manage fatigue

Anti-TNF drug preserves beta-cell function in newly diagnosed pediatric patients with Type 1 diabetes

Researchers create superior bone grafts using primitive stem cells

Research team generates comprehensive developmental map of human T-cells

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Arthritis News and Research

Latest Arthritis News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in